Open AccessEffectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report
Author(s) -
Yuji Yamashita,
Yuko Tanaka,
Seishi Kono,
Meiko Nishimura,
Toru Mukohara,
Yukiko Morinaga,
Shigeo Hara,
Shintaro Takao
Publication year - 2017
Publication title -
breast care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.767
H-Index - 30
eISSN - 1661-3805
pISSN - 1661-3791
DOI - 10.1159/000457948
Subject(s) - medicine , pertuzumab , inflammatory breast cancer , breast cancer , docetaxel , oncology , trastuzumab , chemotherapy , neoadjuvant therapy , regimen , axillary lymph nodes , cancer
Inflammatory breast cancer (IBC) is the most aggressive form of primary breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom